Video
Refractory RA responds to vagus nerve stimulation
MADRID – Pilot trial of a vagus nerve stimulator device shows relative safety and signs of efficacy over 12 weeks.
Article
Partners in Oncology Care: Coordinated Follicular Lymphoma Management
Four case examples illustrate the important role of multidisciplinary medical care for the optimal long-term care of patients with follicular...
News
Medical cannabis legalization outpacing evidence
SAN FRANCISCO – Sparse evidence on cannabis is based on observational studies – not RCTs, said Dr. Kevin P. Hill.
News
AML variants before transplant signal need for aggressive therapy
AMSTERDAM – Patients who had genomic evidence of a lingering AML variant had worse posttransplant outcomes when they underwent reduced-intensity...
News
For tough AML, half respond to selinexor plus chemotherapy
AMSTERDAM – The addition of selinexor looks promising in relapsed/refractory AML, but Karyopharm Therapeutics will be focusing first on approval...
News
Day 75 is key threshold in FVIII inhibitor development
For previously untreated patients with severe hemophilia A, the risk for developing factor VIII inhibitors is near zero after 75 exposure days.
News
Postholiday colonoscopies have lower rates of good bowel prep
SAN DIEGO – The greatest likelihood of adequate preparation was early in the day, but later in the week.
News
Medicare may best Medicare Advantage at reducing readmissions
Editorialists provide reasons to exercise caution when interpreting the results.
News
About one in four youths prescribed stimulants also use the drugs nonmedically
SAN ANTONIO – Most youth who reported nonmedical use of prescription stimulants in a survey were also appropriately prescribed the drugs.
News
Imaging predicts early postural instability in Parkinson’s disease
PHILADELPHIA – Using imaging and clinical data, researchers developed a seven-item scale to identify patients with...